Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Villa

Showing results (541-550 of 566) with videos related to

Pageof 57
Sort By:
The Journal of Infectious Diseases|October 26, 2014
Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) StudyDonna J Ingles, Christine M Pierce Campbell, Jane A Messina, et al.
Vaccine|July 3, 2025
Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201Anna R Giuliano, Anna Beltrame, Luisa L Villa, et al.
The Journal of Infection|May 3, 2026
Genotype Distribution of Human Papillomavirus (HPV) Types in Oral Gargle Specimens among Men Living with HIV in Mexico, Brazil, and Puerto Rico: a Cross-Sectional StudyAnna Beltrame, Anna R Giuliano, Luisa L Villa, et al.
Journal of Virology|October 18, 2005
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16Itzel E Calleja-Macias, Luisa L Villa, Jose C Prado, et al.
Scientific Reports|May 29, 2026
Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trialAnna Beltrame, Luisa L Villa, Eduardo Lazcano-Ponce, et al.
Frontiers in Oncology|December 17, 2020
Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical CancerRenata A M Rossetti, Ildefonso A da Silva-Junior, Gretel R Rodríguez, et al.
Vaccine|May 15, 2007
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccineSven-Eric Olsson, Luisa L Villa, Ronaldo L R Costa, et al.
Med (New York, N.Y.)|April 19, 2021
Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human PrimatesDaniela I Staquicini, E Magda Barbu, Rachel L Zemans, et al.
Revista De Gastroenterologia De Mexico (English)|September 13, 2025
Consensus on the diagnosis, treatment, and follow-up in children and adolescents with overweight and obesity of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)Y Rivera-Suazo, J Alberto-Meléndez, J E Alfaro-Bolaños, et al.
Virology|July 26, 2005
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18Jose C Prado, Itzel E Calleja-Macias, Hans-Ulrich Bernard, et al.
Pageof 57

Showing results (541-550 of 566) with videos related to

Sort By:
Pageof 57
The Journal of Infectious Diseases|October 26, 2014
Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV Infection in Men (HIM) StudyDonna J Ingles, Christine M Pierce Campbell, Jane A Messina, et al.
Vaccine|July 3, 2025
Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201Anna R Giuliano, Anna Beltrame, Luisa L Villa, et al.
The Journal of Infection|May 3, 2026
Genotype Distribution of Human Papillomavirus (HPV) Types in Oral Gargle Specimens among Men Living with HIV in Mexico, Brazil, and Puerto Rico: a Cross-Sectional StudyAnna Beltrame, Anna R Giuliano, Luisa L Villa, et al.
Journal of Virology|October 18, 2005
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16Itzel E Calleja-Macias, Luisa L Villa, Jose C Prado, et al.
Scientific Reports|May 29, 2026
Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trialAnna Beltrame, Luisa L Villa, Eduardo Lazcano-Ponce, et al.
Frontiers in Oncology|December 17, 2020
Local and Systemic STAT3 and p65 NF-KappaB Expression as Progression Markers and Functional Targets for Patients With Cervical CancerRenata A M Rossetti, Ildefonso A da Silva-Junior, Gretel R Rodríguez, et al.
Vaccine|May 15, 2007
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccineSven-Eric Olsson, Luisa L Villa, Ronaldo L R Costa, et al.
Med (New York, N.Y.)|April 19, 2021
Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human PrimatesDaniela I Staquicini, E Magda Barbu, Rachel L Zemans, et al.
Revista De Gastroenterologia De Mexico (English)|September 13, 2025
Consensus on the diagnosis, treatment, and follow-up in children and adolescents with overweight and obesity of the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)Y Rivera-Suazo, J Alberto-Meléndez, J E Alfaro-Bolaños, et al.
Virology|July 26, 2005
Worldwide genomic diversity of the human papillomaviruses-53, 56, and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18Jose C Prado, Itzel E Calleja-Macias, Hans-Ulrich Bernard, et al.
Pageof 57